Matthew Hadfield, DO, discusses what community oncologists should know about immunotherapy toxicities.
Matthew Hadfield, DO
Matthew Hadfield, DO, is a third-year hematology/oncology fellow at Brown University.
Articles by Matthew Hadfield, DO
Matthew Hadfield, DO, discusses his interest in immunotherapy and the toxicities associated with them.
Matthew Hadfield, DO, discusses his passion for early-stage clinical trials and the need for more research into immunotherapy toxicities during the third episode of Emerging Experts.